{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:51Z","timestamp":1790985291564,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["106209"],"award-info":[{"award-number":["106209"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tranon.2021.101307","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:43:02Z","timestamp":1639143782000},"page":"101307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Hiroki","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Imazeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamato","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Kudo-Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2021.101307_bib0001","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1007\/s13277-013-1426-3","article-title":"Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites","volume":"35","author":"Fang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tranon.2021.101307_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12957-019-1761-y","article-title":"Issues on peritoneal metastasis of gastric cancer: an update","volume":"17","author":"Wang","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2021.101307_bib0003","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/cancers11111662","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer","volume":"11","author":"Gamboa","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2021.101307_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5230\/jgc.2020.20.e15","article-title":"Recent advances in intra-peritoneal chemotherapy for gastric cancer","volume":"20","author":"Chia","year":"2020","journal-title":"J. Gastric Cancer"},{"key":"10.1016\/j.tranon.2021.101307_bib0005","first-page":"6991","article-title":"Mechanisms of peritoneal dissemination in gastric cancer","volume":"14","author":"Sun","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2021.101307_bib0006","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3390\/cancers12082236","article-title":"Predicting peritoneal dissemination of gastric cancer in the era of precision medicine: molecular characterization and biomarkers","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2021.101307_bib0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14737140.2020.1718496","article-title":"Novel therapeutic targets for cancer metastasis","volume":"20","author":"Stoletov","year":"2020","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.tranon.2021.101307_bib0008","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/cancers13030554","article-title":"Targeting oncoimmune drivers of cancer metastasis","volume":"13","author":"Kudo-Saito","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2021.101307_bib0009","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.7150\/jca.31787","article-title":"Macrophages on the peritoneum are involved in gastric cancer peritoneal metastasis","volume":"10","author":"Song","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2021.101307_bib0010","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI80007","article-title":"Immunity, inflammation, and cancer: an eternal fight between good and evil","volume":"125","author":"Shalapour","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2021.101307_bib0011","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tranon.2021.101307_bib0012","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101307_bib0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2021.101307_bib0014","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-13-1349","article-title":"Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H","volume":"74","author":"Kudo-Saito","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2021.101307_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fonc.2014.00123","article-title":"Size does matter: why polyploid tumor cells are critical drug targets in the war on cancer","volume":"4","author":"Coward","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2021.101307_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/onc.2013.96","article-title":"Generation of cancer stem-like cells through the formation of polyploid giant cancer cells","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2021.101307_bib0017","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/pros.23877","article-title":"Polyploid giant cancer cells: unrecognized actuators of tumorigenesis, metastasis, and resistance","volume":"79","author":"Amend","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.tranon.2021.101307_bib0018","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1158\/0008-5472.CAN-19-2235","article-title":"IL33 is a key driver of treatment resistance of cancer","volume":"80","author":"Kudo-Saito","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2021.101307_bib0019","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tranon.2021.101307_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2021.101307_bib0021","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","article-title":"Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets","volume":"31","author":"Rochette","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tranon.2021.101307_bib0022","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3389\/fphys.2018.01712","article-title":"GDF15 and growth control","volume":"9","author":"Emmerson","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tranon.2021.101307_bib0023","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.21873\/anticanres.11477","article-title":"MIC1\/GDF15 as a bone metastatic disease biomarker","volume":"37","author":"Windrichova","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tranon.2021.101307_bib0024","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10585-020-10041-3","article-title":"Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients","volume":"37","author":"Spanopoulou","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.tranon.2021.101307_bib0025","first-page":"938","article-title":"Expression profiledriven discovery of AURKA as a treatment target for liposarcoma","volume":"55","author":"Yen","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tranon.2021.101307_bib0026","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2021.03.028","article-title":"Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer","volume":"509","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2021.101307_bib0027","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fonc.2015.00278","article-title":"Aurora kinase inhibitors: current status and outlook","volume":"5","author":"Bavetsias","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2021.101307_bib0028","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2021.101307_bib0029","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-015-0277-8","article-title":"The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer","volume":"34","author":"Fei","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2021.101307_bib0030","doi-asserted-by":"crossref","first-page":"11935","DOI":"10.1038\/s41598-018-29817-5","article-title":"Dysregulation in actin cytoskeletal organization drives increased stiffness and migratory persistence in polyploidal giant cancer cells","volume":"8","author":"Xuan","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2021.101307_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3892\/or.2021.8057","article-title":"CD244(+) polymorphonuclear myeloidderived suppressor cells reflect the status of peritoneal dissemination in a colon cancer mouse model","volume":"45","author":"Sugita","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2021.101307_bib0032","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1007\/s13277-015-3133-8","article-title":"Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients","volume":"36","author":"Wertel","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tranon.2021.101307_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1919082","article-title":"Beyond T Cells: understanding the role of PD-1\/PD-L1 in tumor-associated macrophages","volume":"2019","author":"Lu","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.tranon.2021.101307_bib0034","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12885-020-6629-6","article-title":"Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients","volume":"20","author":"Kono","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2021.101307_bib0035","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1085146","article-title":"PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity","volume":"5","author":"Lim","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.tranon.2021.101307_bib0036","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2021.101307_bib0037","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cam4.1518","article-title":"Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases","volume":"7","author":"Dhupkar","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2021.101307_bib0038","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/d41573-019-00167-9","article-title":"Immuno-oncology drug development goes global","volume":"18","author":"Xin Yu","year":"2019","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321002989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321002989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:22:13Z","timestamp":1761844933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321002989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"alternative-id":["S1936523321002989"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101307","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101307"}}